drugset
Drugs / Cold-adapted influenza vaccine trivalent (CAIV-T)
last change Nov 2002 re-read 3 minutes ago

Cold-adapted influenza vaccine trivalent (CAIV-T)

Vaccine

Developed for
influenza
Investigated by
MedImmune LLC · Wyeth is now a wholly owned subsidiary of Pfizer

Trials 1

today NCT00192413 · Ph 3
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00192413 Mar → Nov 2002 influenza MedImmune LLC Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Cold-adapted influenza vaccine trivalent (CAIV-T) ClinicalTrials.gov intervention name — accepted as the source's own label NCT00192413 ↗
Modality Vaccine “influenza virus vaccine” NCT00192413 ↗
Route Intranasal “administered intranasally” NCT00192413 ↗